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ATF3: activating transcription factor 3 
CCL2: C-C motif chemokine ligand 2 
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IBA-1: ionized calcium-binding adapter molecule 1 
NeuN: neuronal nuclei 
RT: room temperature 
SNI: spared nerve injury  
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Neuron–immune interaction in the dorsal root ganglia (DRG) plays a pivotal role in 
neuropathic pain development after nerve injury. Sigma-1 receptor (Sig-1R) is 
expressed by DRG neurons but its role in neuropathic pain is not fully understood. We 
investigated the effect of peripheral Sig-1R on neuroinflammation in the DRG after 
spared (sciatic) nerve injury (SNI) in mice. Nerve injury induced a decrease in NeuN 
staining along with nuclear eccentricity and ATF3 expression in the injured DRG. Sig-
1R was present in all DRG neurons examined, and after SNI this receptor translocated 
to the periphery of the soma and the vicinity of the nucleus, especially in injured ATF3+ 
neurons. In WT mice, injured DRG produced the chemokine CCL2, and this was 
followed by massive infiltration of macrophages/monocytes, which clustered mainly 
around sensory neurons with translocated Sig-1R, accompanied by robust IL-6 increase 
and mechanical allodynia. In contrast, Sig-1R knockout (Sig-1R-KO) mice showed 
reduced levels of CCL2, decreased macrophage/monocyte infiltration into DRG, and 
less IL-6 and neuropathic mechanical allodynia after SNI. Our findings point to an 
important role of peripheral Sig-1R in sensory neuron–macrophage/monocyte 
communication in the DRG after peripheral nerve injury; thus, these receptors may 
contribute to the neuropathic pain phenotype. 
 




Neuropathic pain, caused by a lesion or disease of the somatosensory nervous system, 
has an estimated prevalence of 7–10% in the general population (1). The quality of life 
of patients with neuropathic pain is greatly impaired, and unfortunately, neuropathic 
pain management constitutes a substantially unmet clinical need (2). Therefore, 
understanding the pathophysiological mechanisms involved in neuropathic pain is 
essential to identify novel therapeutic targets and develop new analgesic drugs (3, 4). 
Sigma-1 receptor (Sig-1R) is a ligand-operated chaperone with an important 
neuromodulatory role (5, 6). This receptor is located within the nervous system in 
anatomical areas important for pain control (6), where it plays a pivotal role in 
neuropathic pain (6, 7). Neuropathic pain-like behaviors are diminished in Sig-1R 
knockout (Sig-1R-KO) mice (8-11) and in wild-type (WT) animals treated with Sig-1R 
antagonists (9, 11, 12-15). The important effects of Sig-1R on neuropathic pain in 
preclinical studies have led to the development of a Sig-1R antagonist (13), which is 
currently under clinical development for the treatment of neuropathic pain (16, 17). 
The mechanisms involved in neuropathic pain amelioration induced by Sig-1R 
inhibition have been studied mainly in the central nervous system, where this receptor is 
known to modulate central sensitization after peripheral nerve injury (reviewed in 6). 
Furthermore, Sig-1R inhibition decreased neuroinflammation in the spinal cord in 
models of pathological pain, reducing the proinflammatory cytokine content (18-20) 
and attenuating astrocyte and microglia activation (18, 21, 22) – changes which are all 
known to contribute to pain hypersensitivity (23). 
In addition to central changes, chronic pain such as that produced after 
peripheral nerve injury also produces alterations in axotomized neurons of the dorsal 
root ganglia (DRG) (24-26). For example, whereas the nuclei of intact peripheral 
sensory neurons are located in a central position, axotomized neurons have eccentric 
nuclei (27), and express several transcription factors including activating transcription 
factor 3 (ATF3) (28). Injured DRG neurons recruit immune cells into the ganglia, 
mainly through the release of the chemokine CCL2 (C-C motif chemokine ligand 2) 
(29). The recruitment of immune cells such as peripheral macrophages into the DRG 
plays an active role in neuropathic pain through the local release of proinflammatory 
algogenic mediators which can sensitize neighboring uninjured neurons (23). Spared 
nerve injury (SNI) model of neuropathic pain is ideal for the study of these key features 
of neuropathic pain in the DRG, since the transection of the tibial and common peroneal 
branches of the sciatic nerve in the SNI leads to neuropathic hypersensitivity in the 
intact sural territory, due (at least partially) to the previously commented 
neuroinflammation in the affected DRG, where the somas of injured and uninjured 
neurons coexist (28, 30). 
Interestingly, Sig-1R expression is much higher in the DRG than in the dorsal 
spinal cord (31), and in fact, Sig-1R is expressed by every single DRG neuron (32). We 
have recently described that Sig-1R inhibition attenuates neuropathic pain-like 
behaviors associated with the spared nerve injury (SNI) in mice (11). However, whether 
Sigma-1R are able to modulate neuroinflammation in the DRG is unknown. 
In light of these antecedents and the gaps in our understanding of how Sig-1R 
influences neuropathic pain, the main aim of this study was to evaluate the possible 
contribution of peripheral Sig-1R to the neuroinflammation that takes place in the DRG 
after SNI. 
 
MATERIAL AND METHODS 
Animals 
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Experiments were performed in female WT (Charles River, Barcelona, Spain) and Sig-
1R-KO CD-1 mice (Esteve Pharmaceuticals, Barcelona, Spain) weighing 26–32 g (8- to 
11-weeks-old). Knockout mice were generated on a CD-1 background as previously 
described (33), by using a traditional backcrossing breeding strategy with WT 
progenitors from Charles River for at least 15 generations, which theoretically ensured 
that the genetic material from the original background is virtually absent (34). Mice 
harboring the mutation were then bred to homozygosity and used in this study. The 
animals were housed in colony cages with free access to food and water prior to the 
experiments. They were maintained in light- and temperature -controlled rooms (23 ± 
2 °C, lights on at 07.00 h and off at 19.00 h). The animals were tested at random times 
throughout the estrous cycle. Animal care was in accordance with institutional 
(Research Ethics Committee of the University of Granada, Spain), regional (Junta de 
Andalucía, Spain) and international standards (European Communities Council 
Directive 2010/63). To decrease the number of animals in this study, we used the same 
mice for behavioral and in vitro studies, when possible. 
 
Spared nerve injury 
The spared nerve injury (SNI) was induced as previously described (35). Briefly, an 
incision was made in the left skin at the site of trifurcation of the sciatic nerve, and its 
three terminal branches (the sural, common peroneal and tibial nerves) were exposed. 
The tibial and common peroneal branches were ligated with a silk suture and transected 
distally, while the sural nerve was left intact. In sham-operated control mice, the sciatic 
nerve terminal branches were exposed but not ligated. Mice were anesthetized with 
isoflurane 3% (Braun VetCare, Barcelona, Spain) during the procedure. We monitor 
carefully for signs of distress after surgery. Although mice can move, rise and get access 
to food and water normally after surgery, we place some food pellets on the cage floor 
to facilitate access to them. Autotomy behavior was not observed in any animal 
following SNI during this study. 
 
Assessment of mechanical allodynia 
Mechanical thresholds were tested before surgery (baseline) and 3 and 7 days after SNI. 
Mechanical allodynia was assessed with von Frey filaments according to a previously 
described method, with slight modifications (36). On each day of evaluation the mice 
were habituated for 60 min in individual transparent plastic chambers (7 × 7 × 13 cm) 
with a floor made of wire mesh. After the adaptation period, calibrated von Frey 
monofilaments (Stoelting, Wood Dale, IL, USA) with bending forces that ranged from 
0.02 to 2 g were applied with the up–down paradigm in the sural nerve territory, starting 
with the 0.6 g filament. The response to the filament was considered positive if 
immediate flinching, licking/biting or rapid withdrawal of the stimulated paw was 
observed. In each consecutive test, if there was a positive response, a weaker filament 
was then used; if there was no response to the filament, a stronger stimulus was then 
selected. Behavioral evaluations were performed by an observer blinded to the mouse 
genotypes in all experiments. 
 
Assessment of burrowing behavior 
Laboratory mice are fossorial animals, and therefore naturally burrow to hide from 
predators. This innate behavior can be used to detect distress and suffering in rodents, 
including neurological deficits and sickness behavior (37). More recently, burrowing 
behavior has been used to detect the effects of pain on the general condition of rodents 
(38). We used burrows whose design was adapted from (39). Burrows were made in-
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house and consisted of hollow plastic tubes (68 mm diameter × 225 mm length). One 
end of the burrowing tube was sealed with a plastic cap. Burrows were filled with 
normal diet food pellets, and the open end was raised 30 mm above the cage floor, to 
minimize pellets drop when placed in the testing cage. Every experimental day, mice 
were habituated in individual cages in the testing room for 30 minutes. The first day, 
mice were acclimatized in their cages with the empty tube for 15 min before the 
burrowing assay, in order to reduce the effects of novelty. Testing was conducted during 
the first hour of the animals’ light cycle. Burrowing behavior was tested by placing the 
filled tube into the cage for 30 min. The procedure was repeated three days in each 
animal: one training day, a second consecutive day to determine the baseline activity of 
burrowing before surgery and 7 days after SNI. During the period of the assay, each 
animal was always placed in the same cage with the same tube without food and water. 
Lipopolysaccharides (LPS) administration was used as a positive control since it is 
known to induce sickness behavior and to dramatically reduce burrowing behavior. 
After determining the basal burrowing activity, LPS (L5886, Sigma-Aldrich, Madrid, 
Spain) at a dose of 500 µg/kg, or sterile physiological saline, was administered 
intraperitoneally (i.p.) in a volume of 10 ml/kg. Burrowing behavior was measured 3 
hours after the injection (40). 
The burrowing activity was calculated by subtracting the weight of remained pellets in 
the tube at the end of assay, from the starting weight of the total amount of pellets, and 
expressing the proportion of displaced pellets as a percentage. 
 
Immunohistochemistry 
All experiments were performed in lumbar L4 DRG, since the somas of the common 
peroneal/tibial branches of the sciatic nerve and those from the sural nerve in mice are 
located at this level (28). This made it possible to immunostain injured and non-injured 
neurons at this location simultaneously. 
On day 7 after surgery, SNI mice were anesthetized with isoflurane 4% and 
perfused transcardially with 0.9% saline solution followed by 4% paraformaldehyde 
(Sigma-Aldrich, Madrid, Spain). The DRG were excised and post-fixed for 1 h (4 °C) in 
the same fixative solution. Samples were dehydrated and embedded in paraffin with 
standard produces. Sections of DRG were serially cut on a sliding microtome at 5 μm 
and mounted on microscope slides (Sigma-Aldrich). Slides containing every tenth 
section of L4 DRG were deparaffinized in xylol (Panreac Quimica, Castellar del Vàlles, 
Spain), and rehydrated with alcohol (Panreac Quimica) and distilled water before the 
antigen retrieval procedure (steam heating for 22 min with 1% citrate buffer, pH 8). 
Tissue sections were incubated for 60 min in a blocking solution that contained 5% 
normal goat or horse serum (Sigma-Aldrich) depending on the experiment, 0.3% Triton 
X-100 (Sigma-Aldrich) and 0.1% Tween 20 (Sigma-Aldrich) in Tris buffer solution at 
room temperature (RT). Then the slides were incubated with the primary antibodies in 
blocking solution. The primary antibodies used were rabbit anti-ATF3 (1:200, sc-188, 
Santa Cruz Biotechnology, Inc., Heidelberg, Germany), mouse anti-Sig-1R (1:200, sc-
137075, Santa Cruz Biotechnology), rabbit anti-ionized calcium-binding adapter 
molecule 1 (IBA-1, 1:200, 019-19741, Wako Chemical, Neuss, Germany), rabbit anti-
NeuN (neuronal nuclei) (1:500, ABN78, Merck Millipore, MA, USA) and rabbit anti-
PGP 9.5 (1:400, AB1761, Merck Millipore). Incubation with the primary antibodies for 
Sig-1R, NeuN, PGP 9.5 and IBA-1 lasted for 1 h (RT), whereas incubation with the 
primary antibody for ATF3 lasted overnight (4 °C). After incubation with the primary 
antibodies, the tissue sections were washed three times for 10 min and incubated for 1 h 
(RT) with the appropriate secondary antibody solution containing goat anti-mouse 
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Alexa Fluor 488 (A11029), goat anti-rabbit Alexa Fluor 488 (A11008), or goat anti-
rabbit Alexa Fluor 594 (A11012) (all 1:500, all from Life Technologies, Carlsbad, CA, 
USA), depending on the experiment. We also stained some tissue sections with NeuN 
conjugated with Alexa Fluor 555 (1:500, MAB377A5, Merck Millipore) and Alexa 
Fluor 488 (1:500, MAB377X, Merck Millipore). 
The slides were then washed three times for 10 min and coverslipped with 
ProLong® Gold Antifade mounting medium (Molecular Probes; Oregon, USA). In 
some experiments, slides were incubated for 5 min (RT) with Hoescht 33342 (1:1000, 
Sigma-Aldrich) and washed three times before the mounting procedure. Slides were 
visualized under a confocal laser-scanning microscope (Model A1, Nikon Instruments 
Europe BV, Amsterdam, Netherlands) and processed with Image-J software (version 
1.48, Wayne Rasband, NIH, Bethesda, MD, USA). For quantifications based on 
inmunohistochemical images, the data were obtained in 3–6 ipsilateral or contralateral 
sections per mouse, from at least 4 mice. To study macrophage infiltration into the 
DRG, double positive immunoreactivity for IBA-1 (as a macrophage/monocyte marker) 
and Hoechst 33342 was quantified in 4 areas (100 × 100 µm) located randomly in each 
DRG section. For the remaining quantifications, whole DRG sections were used instead 
of random areas. To estimate the percentage of DRG neurons with macrophage ring-like 
structures closely adhered to the neuronal surface, only neurons with at least 25% of 
their plasma membrane surrounded by IBA-1 staining were counted, as previously 
described (41). Quantitative data were recorded by an observer blinded to the mouse 
genotype and the type of sample (naive, ipsilateral or contralateral to the SNI). 
 
Fluorescence-activated cell sorting (FACs) 
For these experiments, we selected L3 and L4 DRG since they contained all somas from 
the common peroneal and tibial branches of the sciatic nerve (28), and therefore 
contained all neurons injured after SNI. Each assay was performed in samples with L3 
and L4 DRG from 3 animals. The DRG were dissected and digested with collagenase 
IV (1 mg/mL, LS004188, Worthington, Lakewood, NJ, USA) and DNAse I (0.1%, 
LS002007, Worthington) for 1 h at 37 °C with agitation, and then with trypsin (0.25%, 
15400054, Thermo Fisher Scientific, Massachusetts, USA) for 7 min at 37 °C with 
agitation. The digestion was neutralized with fetal bovine serum (FBS) (10%, 16000-
036, Thermo Fisher Scientific) in phosphate-buffered saline (PBS). Cells were gently 
pipetted up and down to obtain a single cell suspension. Samples were filtered (pore 
size 35 μm) and the rat anti-CD32/16 antibody (1:100, 20 min, 553141; Biolegend, San 
Diego, CA) was used to block Fc-γRII (CD32) and Fc-γRIII (CD16) binding to IgG. 
Cells were incubated with antibodies recognizing the hematopoietic cell marker CD45 
(1:200, 103108, clone 30-F11, Biolegend), the myeloid marker CD11b (1:100, 101227, 
clone M1/70, Biolegend), and the neutrophil-specific marker Ly6G (1:100, 127617, 
clone 1A8, Biolegend), together with a viability dye (1:1000, 65-0865-14, Thermo 
Fisher Scientific), for 30 min on ice. The populations of macrophages/monocytes 
(CD45+CD11b+Ly6G− cells) and neutrophils (CD45+CD11b+Ly6G+ cells) were 
determined from the markers indicated above in cells labelled with the viability dye.  
 Before and after incubation with the antibodies, the cells were washed three 
times in 2% FBS/PBS (FACS buffer). Cells were fixed with paraformaldehyde (2%, 
158127, Sigma-Aldrich) for 20 min, and on the next day samples were assayed with a 
BD FACSCanto II flow cytometer (BD Biosciences, San Jose, CA, USA). 
Compensation beads were used as compensation controls, and fluorescence minus one 
(FMO) controls were included to determine the level of nonspecific staining and 
8 
autofluorescence associated with different cell subsets. All data were analyzed with 
FlowJo 2.0 software (Treestar, Ashland, OR, USA).  
 
Cytokine and chemokine measurement assays in DRG 
L3 and L4 DRG were excised and homogenized by sonication in 50 μL RIPA (0278, 
Sigma-Aldrich) supplemented with protease inhibitors (0.5%, P8340, Sigma-Aldrich) 
and phosphatase inhibitors (1%, P0044, Sigma-Aldrich). Ipsilateral or contralateral 
DRG from three mice were pooled, homogenized and tested as a single sample. Protein 
concentration in tissue homogenates was measured with the Bradford assay. The 
samples were stored at −80 °C until use.  
For the determination of CCL2, twenty micrograms of protein was loaded in each well, 
and CCL2 levels were quantified with an enzyme-linked immunosorbent assay (ELISA) 
according to the manufacturer’s instructions (MJE00, R&D Systems, Abingdon, United 
Kingdom). For the determination of IL-6, IL-1 and TNF, twenty micrograms of 
protein was loaded in each well, and levels of the three cytokines were quantified in the 
same samples with a Luminex-based multiplex immunoassay according to the 
manufacturer’s instructions (MHSTCMAG-70K, Merck, Darmstadt, Germany) 
 
Data analysis 
For behavioral studies, statistical analyses were done with two-way repeated measures 
analysis of variance (ANOVA). For immunofluorescence quantification assays, 
statistical analyses were done with one- or two-way ANOVA, or the unpaired Student’s 
t test depending on the experiment. For FACs,  ELISA and multiplex studies, statistical 
analyses were done with two-way ANOVA. The Bonferroni post hoc test was used for 
all ANOVA results. The differences between values were considered significant when 
the P value was less than 0.05. All data were analyzed with SigmaPlot 12.0 software 




Sig-1R-KO mice show reduced mechanical allodynia after SNI 
We compared the response to mechanical stimulation after SNI in WT and Sig-1R-KO 
mice. Both groups had similar von Frey thresholds in the hind paw before surgery (Fig. 
1). After SNI, mechanical thresholds in the paw contralateral to surgery were similar to 
the baseline values in both Sig-1R-KO and WT animals (Fig. 1). No change was 
observed in pain thresholds in sham-operated control mice (data not shown). However, 
WT mice progressively developed mechanical allodynia in the injured limb, manifested 
as a significant reduction in the mechanical threshold in the paw ipsilateral to the injury 
starting 3 days after surgery, and peaking 7 days after SNI (Fig. 1). In contrast, Sig-1R-
KO mice developed significantly less mechanical hypersensitivity compared to WT 
mice after SNI (Fig. 1). 
Therefore, SNI induced sensory hypersensitivity in the injured limb but not in 
the side contralateral to the nerve injury in both WT and Sig-1R-KO mice. However, 
animals lacking Sig-1R developed attenuated neuropathic allodynia. 
 
Burrowing behavior was not altered after SNI 
We compared the burrowing behavior in WT and Sig-1R-KO mice before and after 
SNI. Uninjured mice from both genotypes showed a similar percentage of pellets 
displaced from the burrowing tube at baseline measurement and 7 days after baseline 
recording (Supplemental Fig. 1A), indicating that the mutant mice do not exhibit 
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neurological alterations which interfere with this complex behavior. Both WT and Sig-
1R-KO mice, 7 days after SNI surgery showed also similar values of pellets displaced 
during burrowing, which were equivalent to the baseline recording (Supplemental Fig. 
1A). Therefore, SNI was unable to induce any apparent decrease in burrowing behavior 
in either genotype. However, the percentage of pellets displaced from the burrowing 
tube dramatically dropped 3 hours after LPS administration to WT mice, when 
compared with control group administered with saline (Supplemental Fig. 1B). These 
results indicate that sickness behavior, in contrast to neuropathic pain, robustly interfere 
with this behavior.  
 
Subcellular Sig-1R distribution in DRG is altered in injured neurons after SNI in 
WT mice 
To study the expression of Sig-1R in the DRG after SNI, we used immunofluorescence 
double labeling for Sig-1R and the neuronal markers NeuN (Fig. 2A) or PGP 9.5 (Fig. 
2B). The double labeling with Sig-1R and NeuN, showed that Sig-1R was expressed by 
all DRG neurons (NeuN-expressing cells) from naive WT mice (Fig. 2A, left panels), 
and that Sig-1R staining was still markedly present after SNI in DRG ipsilateral or 
contralateral to the surgical injury (Fig. 2A, middle and right panels). In contrast, some 
cells, with a clear neuronal morphology, showed Sig1-R staining in DRG ipsilateral to 
the SNI but no appreciable NeuN labeling (see white arrows in Fig. 2A, middle panels). 
Sig-1R immunolabeling was completely absent in both naive and Sig-1R-KO mice after 
SNI (Supplemental Fig. 2), indicating the specificity of Sig-1R staining. 
At higher magnification, variable degrees of NeuN staining intensity were 
evident in DRG ipsilateral to the SNI. Some neurons showed faint or no staining for 
cytoplasmic NeuN, although they retained NeuN labeling in the nucleus (Supplemental 
Fig. 3, middle panels) and showed strongly positive labeling for the cellular stress 
marker ATF3, whereas neurons with intense NeuN labeling showed no ATF3 staining 
(Supplemental Fig. 3, lower panels). Neurons in DRG from naive mice and in DRG 
contralateral to the SNI showed prominent NeuN staining but no ATF3 labeling 
(Supplemental Fig. 3, left and right panels). Therefore, ATF3-expressing neurons 
showed less NeuN staining, and were found exclusively in injured DRG. 
Immunofluorescence double labeling for NeuN and PGP 9.5 shows that whereas 
PGP 9.5 staining was still normally present after SNI, NeuN expression was reduced or 
absent in some DRG neurons (PGP 9.5+ cells) ipsilateral to the injury (Supplemental 
Fig. 4). These results indicate that PGP 9.5, in contrast to NeuN, stained consistently 
both injured and uninjured neurons. We then analyzed the double staining of Sig-1R 
and PGP 9.5, and confirmed that Sig-1R labeling was present in all neurons (PGP 9.5-
expressing cells) either from non-injured or injured DRG samples (Fig. 2B). Higher 
magnification images of the double staining of Sig-1R and PGP 9.5 showed that Sig-1R 
labeling is restricted to PGP 9.5-expressing cells, in DRG samples from either naive or 
SNI mice  (Fig. 3A), indicating that Sig-1R is selectively expressed in neurons in the 
DRG and that nerve injury does not alter this selectivity in the expression of Sig-1R. 
Interestingly, most Sig-1R staining was relatively homogeneous within DRG 
neurons from naive mice and in DRG contralateral to the injury (Fig. 3A and 3B, left 
and right panels), although in some neurons Sig-1R staining was concentrated at the 
periphery of the soma and the vicinity of the nucleus (which was devoid of Sig-1R 
staining) in DRG ipsilateral to the SNI (Fig. 3A and B, middle panels). We observed 
markedly more Sig-1R translocation in DRG neurons from the side ipsilateral to the 
SNI compared to DRG from naive animals and from the side contralateral to the injury 
(Fig. 3C). Most of the DRG neurons with evidence of Sig-1R translocation after SNI 
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also had eccentric nuclei (Fig. 3A and B, middle panels). Since eccentric nuclei is a sign 
of axotomy, we performed double labeling of Sig-1R with ATF3. We found that most 
neurons showing Sig-1R translocation (78.4%) in the DRG ipsilateral to the SNI also 
expressed ATF3 in the cell nucleus (Fig. 3B, middle panels and Fig. 3D). 
In summary, SNI induced nuclear eccentricity, a decrease in NeuN staining, and 
ATF3 expression in neurons from injured DRG. These changes were accompanied by a 
change in the subcellular distribution of Sig-1R in sensory neurons, i.e. translocation to 
the periphery of the soma and the vicinity of the cell nucleus. 
 
Macrophage/monocyte infiltration and IL-6 levels in the DRG after SNI are 
modulated by Sig-1R 
Because the infiltration of immune cells into the DRG after peripheral nerve injury 
plays a key role in the development of neuropathic pain (see Introduction for 
references), we investigated the infiltration of neutrophils and macrophages/monocytes 
by FACS, in DRG from WT and Sig-1R-KO mice after SNI. We did not find a 
significant infiltration of neutrophils (CD45+CD11b+Ly6G+ cells) in the injured DRG 
at day 1 or 7 after SNI in mice from either genotype (Fig. 4A). However, we found a 
markedly greater presence of macrophages/monocytes (CD45+CD11b+Ly6G− cells) in 
injured DRG from WT mice on day 7 after SNI compared to naive DRG, and this 
increase was largely attenuated in Sig-1R-KO mice (Fig. 4A). DRG samples from the 
side contralateral to the injury from either WT or Sig-1R-KO mice did not show any 
significant increase in the number of either neutrophils or macrophages/monocytes (Fig. 
4B). 
Next, we further investigate by immunohistochemistry the 
macrophage/monocyte infiltration into DRG from WT and Sig-1R-KO mice after SNI. 
Figure 5 shows representative images for the neuronal marker NeuN and the 
macrophage/monocyte marker IBA-1 in DRG from non-injured WT and Sig-1R-KO 
mice, and from samples obtained 7 days after SNI in both genotypes (Fig. 5A). In naive 
WT and Sig-1R-KO animals, little or no appreciable IBA-1 staining was detected (Fig. 
5A, left panels). However, after SNI, macrophages/monocytes clustered around the cell 
bodies of neurons producing ring-like structures in DRG ipsilateral to the injury in WT 
mice, and these neurons often showed decreased NeuN labeling (white arrows in Fig. 
5A, middle panels). IBA1+ cells were still present in Sig-1R-KO animals, but at much 
lower levels than in WT mice (Fig.5A, middle panels). The quantification of IBA-1+ 
cells confirmed the considerable infiltration of macrophages/monocytes into ipsilateral 
DRG in WT mice after SNI (compared to samples from naive animals and samples 
from the side contralateral to the injury), and also showed that the increase in 
macrophage/monocyte numbers in the DRG was smaller in Sig-1R-KO animals (Fig. 
5B). These results are evidence that SNI induced massive macrophage/monocyte 
infiltration into the DRG, and that infiltration was markedly weaker in mice that lacked 
Sig-1R. Accordingly, these findings suggest that Sig-1R plays an important role in 
macrophage/monocyte recruitment after nerve injury. 
We then measured by a multiplex immunoassay the levels of proinflammatory 
cytokines related to macrophages/monocytes (IL-6, IL-1β and TNF) in DRG from 
injured and non-injured WT and Sig-1R-KO mice, at day 7 after SNI. The 
concentrations of IL-1β and TNF were below the detection limit of the assay that we 
employed (data not shown). Non-injured WT and Sig-1R-KO mice had similar levels of 
IL-6 (Fig. 5C). In contrast, the concentration of IL-6 in injured DRG from both WT and 
Sig-1R-KO mice was significantly increased, although at a much lower extent in Sig-
1R-KO mice than in WT mice (Fig. 5C). Therefore, the lower infiltration of 
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macrophages/monocytes into injured DRG in Sig-1R-KO mice that we described above, 
was accompanied by a reduction in the levels of IL-6. 
 We next further investigated the relationship between macrophages/monocytes 
infiltration and the Sig-1R in the DRG following SNI. For this purpose, we carried out 
immunofluorescence double labeling with Sig-1R and the macrophage/monocyte 
marker IBA-1 in WT mice. Figure 6A shows representative images for Sig-1R and 
IBA-1 staining in DRG from naive animals, injured animals, and samples from the side 
contralateral to the injury. In naive animals little or no appreciable IBA-1 staining was 
detected (Fig. 6A, left panels). However, after SNI, macrophages/monocytes clustered 
around the cell bodies in Sig-1R-stained neurons, forming the previously commented 
ring-like structures in the DRG ipsilateral to the injury (Fig. 6A, middle panels). 
However, few or no IBA-1+ cells were detected in DRG contralateral to the nerve 
injury (Fig. 6A, right panels). We observed a minimal overlapping between Sig-1R and 
IBA-1 labeling in the regions where the neuron and macrophage/monocyte are closest 
(Fig. 6A, middle panels), supporting the close neuron–immune cell interaction, and 
suggesting that Sig-1R was expressed in sensory neurons but not in macrophages or 
monocytes. The characteristic ring-like IBA-1 labeling was seen mostly in neurons with 
Sig-1R staining at the periphery of the soma (Fig. 6A middle panels). In fact, a majority 
(69.5%) of neurons with Sig-1R translocation to the periphery of the soma were 
surrounded by macrophages/monocytes, whereas these immune cells rarely 
accumulated around neurons that did not show evidence of Sig-1R translocation: only 
20.5% of neurons without translocation were surrounded by IBA-1+ cells (Fig. 6B). 
These results suggested that Sig-1R might be involved in the communication between 
neurons and macrophages/monocytes. 
 
Sig-1R-KO mice show lower levels of CCL2 in the DRG after SNI than WT mice 
To investigate whether Sig-1R might be relevant for macrophage/monocyte recruitment, 
we next measured the levels of the chemokine CCL2 in DRG from non-injured WT and 
Sig-1R-KO mice, as well as at several time-points after SNI in samples from both 
genotypes. Non-injured mice from both the WT and Sig-1R-KO groups had similar 
baseline levels of CCL2. The concentration of CCL2 in injured DRG from WT mice 
showed a bell-shaped time-course, increasing as early as 24 h after surgery, peaking on 
day 3 after the injury, and subsequently decreasing on day 7 (Fig. 7). Sig-1R-KO mice 
also had increased levels of CCL2 in DRG ipsilateral to the SNI, with a time-course 
similar to that in WT mice, but the increase in CCL2 content was significantly smaller 
that in WT mice (Fig. 7). The increase in CCL2 was restricted to injured DRG, given 
that CCL2 concentration did not change at any time-point tested in the DRG 
contralateral to the injury in either WT or Sig-1R-KO mice. These results suggest that 
Sig-1R modulated CCL2 release in the DRG after SNI. 
 
DISCUSSION 
We show that Sig-1R-KO mice develop less mechanical allodynia than WT mice in 
response to peripheral nerve injury. Spared nerve injury was followed by the presence 
of eccentric nuclei, a decrease in NeuN staining, and ATF3 expression in neurons from 
injured DRG. These changes were accompanied by Sig-1R translocation to the plasma 
membrane (or nearby areas) and the vicinity of the cell nucleus in peripheral sensory 
neurons. In addition, we found an increase in the levels of CCL2, 
macrophage/monocyte numbers and IL-6, in injured DRG. These immune cells formed 
ring-like structures mainly in neurons in which Sig-1R was translocated. In Sig-1R-KO 
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mice the levels of CCL2, macrophage/monocyte infiltration and IL-6 into the DRG 
were lower after nerve injury than in WT mice.  
Peripheral nerve injuries such as nerve transection that takes place during 
surgical procedures or as a consequence of other trauma lead to neuropathic pain in a 
considerable number of patients (42, 43). Here we show that mechanical allodynia in 
the intact sural branch territory of mice, after transection of the common peroneal and 
tibial branches of the sciatic nerve (i.e. SNI), developed progressively in WT animals, 
with a time-course similar to that reported in previous studies based on mouse models 
(11, 30,  44). We show that Sig-1R-KO mice developed significantly less mechanical 
allodynia than WT mice after SNI. This result is in agreement with our recent study in 
the same neuropathic pain model (11), and with previous reports that mutant animals 
lacking Sig-1R developed less sensory hypersensitivity than WT mice in other 
neuropathic pain models (8-10, 45). 
We also found that uninjured WT and Sig-1R-KO mice showed a similar burrowing 
behavior. Although Sig-1R have a known pivotal role on neurotransmission (46, 47), 
this might be more prominent in pain pathways than in other systems, as its absence in 
the mutant mice does not lead to an overt behavioral dysfunction. We show that SNI did 
not depressed burrowing behavior in either WT or Sig-1R-KO mice. Although it has 
been reported that neuropathic pain in rodents decrease burrowing or other innate 
behaviors such as exploratory activity (e.g. 48, 49), this is not always the case (50). 
LPS-induced sickness behavior inhibited burrowing activity, as previously reported 
(40), suggesting that the lack of effect of SNI on this behavior is not due to 
methodological issues. Therefore, although SNI induces prominent allodynia, it does 
not impact on the functionality of the rodents in our burrowing experimental conditions. 
We found that Sig-1R immunoreactivity in normal conditions was expressed in 
the somas of all peripheral sensory neurons from the mouse DRG. The receptor was 
located in the cytoplasm but not inside the cell nucleus, as previously reported (32, 51). 
We show that Sig-1R staining in sensory neurons changed dramatically after nerve 
injury only in DRG from the side ipsilateral to SNI, where it accumulated in the plasma 
membrane (or nearby areas) and in close proximity to the cell nucleus. We 
demonstrated the specificity of the antibody used for Sig-1R staining by verifying the 
absence of immunoreactivity in samples from Sig-1R-KO mice before and after SNI. It 
was previously reported that when Sig-1R is activated by either sigma-1 agonism or 
cellular stress, it translocates from its intracellular location to the plasmalemmal area 
within the extended endoplasmic reticulum (or to the plasma membrane itself) and to 
the nuclear envelope (52, 53, 54). Therefore, the alterations we observed in Sig-1R 
labeling induced by SNI might indicate that nerve injury triggered Sig-1R activation. To 
our knowledge, this is the first experimental evidence that changes in the subcellular 
distribution of Sig-1R are identifiable in DRG neurons after nerve injury. Further 
studies using specific subcellular markers are guaranteed to deepen on the study of this 
process in sensory neurons. 
We show that some DRG neurons from the side ipsilateral to SNI underwent 
other changes in addition to the alterations in subcellular Sig-1R distribution, including 
nuclear eccentricity, which has long been known to be due to severe neuronal damage 
(27, 55), and a marked decrease in NeuN staining. To our knowledge there are no 
previously published studies in DRG tissues that document the decrease in NeuN 
labeling after nerve injury. However, recent studies have questioned the reliability of 
NeuN immunoreactivity as a marker for neuron numbers during certain pathological 
states (56, 57). In particular, it is known that NeuN staining decreases markedly after 
axotomy in several nervous system structures, whereas other neuronal markers do not 
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(e.g. 56, 57). In fact, in the present study, we found that the expression of PGP 9.5 
(another neuronal marker) did not change in DRG neurons ipsilateral to the injury, in 
contrast to the marked decrease in NeuN staining. This decrease in NeuN staining we 
observed in the DRG may reflect changes in injured neurons since it was accompanied 
by a clear increase in ATF3 labeling in the neuronal nucleus – a finding of relevance 
given that ATF3 is considered among the most reliable markers of injury in DRG 
neurons (28, 58). Importantly, we observed that the majority of DRG neurons with Sig-
1R translocation also expressed ATF3, suggesting that Sig-R1 activation (translocation) 
was mostly restricted to injured neurons. 
It is known that nerve injury induces immune cell infiltration into the affected 
DRG (59). We found a marked increase in macrophages/monocytes in the DRG after 
peripheral nerve injury, in agreement with previous studies (30, 60). We did not observe 
increased neutrophil recruitment in the DRG after nerve injury, which is also in 
agreement with previous reports (61). We show that macrophages/monocytes 
accumulated and formed ring-like structures mostly in sensory neurons where Sig-1R 
was translocated. It was previously reported that these ring-like structures are seen 
preferentially in injured neurons (41), a finding consistent with the Sig-1R translocation 
we report here in injured neurons. The accumulation of macrophages/monocytes around 
neurons with translocated Sig-1R may indicate that Sig-1R activation is important for 
the interaction between these immune cells and injured sensory neurons. In support of 
this hypothesis, we show here that in Sig-1R-KO mice, macrophage/monocyte 
infiltration into the DRG after nerve injury was much weaker than in WT mice. It is 
worth noting that under our experimental conditions, labeling for the Sig-1R in DRG 
samples was restricted to sensory neurons, either before or after nerve injury. Therefore, 
the modulation by Sig-1R of macrophage/monocyte infiltration in the DRG after nerve 
injury is unlikely to be attributable to direct sigma-1-mediated effects on these immune 
cells or other cell types, but rather can be explained by curtailed communication 
between neurons and macrophages/monocytes. 
The communication between peripheral sensory neurons and immune cells is 
complex, but currently the role of CCL2 in this interaction is unquestioned. This 
chemokine has potent chemotactic activity and is involved in macrophage recruitment 
in the DRG after nerve injury (62). In this connection, it is well known that injured 
neurons are the main source of this chemokine in DRG after nerve injury (e.g. 29, 63, 
64). In fact, CCL2 blockade results in a decrease in the number of 
macrophages/monocytes that migrate into the DRG after nerve injury (e.g. 61, 65). Thus 
CCL2 is one of the main molecules that mediate macrophage/monocyte recruitment by 
injured neurons in the DRG. Here we show that CCL2 was produced soon after nerve 
injury, with a bell-shaped time-course. The levels of CCL2 increased as early as 1 day 
after injury, reached a maximum at 3 days, but subsequently decreased 7 days after the 
injury. This time-course of CCL2 production after peripheral nerve injury is consistent 
with at least one previous report in another mouse model (63). According to the present 
findings, Sig-1R-KO mice had reduced levels of this chemokine in the injured DRG 
after SNI, and this lower activity may partly account for the decreased 
macrophage/monocyte infiltration in the DRG in our mutant animals after nerve injury. 
Macrophage and monocyte recruitment into the DRG plays a pivotal role in 
neuropathic pain, because they promote a proinflammatory environment in the affected 
ganglia which can in turn sensitize non-injured neurons, and thus contribute to the 
development of sensory hypersensitivity in the intact sural branch territory after SNI 
(30, 66). We found a significant increase in the levels of the proinflammatory cytokine 
IL-6 in the injured DRG following SNI, in agreement with previous studies (41, 67), 
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which was attenuated in Sig-1R-KO mice. Since proinflammatory macrophages are the 
primary source of IL-6 after nerve injury (60, 62), the reduced levels of IL-6 in injured 
DRG of Sig-1R-KO mice might be explained by the reduced infiltration of 
macrophages/monocytes found at this location. In addition, both CCL2 and IL-6 have 
direct effects on sensory neurons in that they increase their excitability (68, 69, 70), and 
importantly, gene expression of both proinflammatory mediators in DRG of human 
patients has been recently reported to be associated to neuropathic pain (71). Altogether, 
the decrease in CCL2 levels and the reduced macrophage/monocyte infiltration into the 
DRG after nerve injury in Sig-1R-KO mice, with the consequent decrease in IL-6, may 
contribute to the lower sensory hypersensitivity we observed in these mutant animals. 
Our results are summarized in Fig. 8. 
It was previously reported that Sig-1R antagonism is also able to decrease 
microglia recruitment and astrocyte activation in the dorsal horn during pathological 
pain conditions, and this might contribute to the known ameliorative effects of Sig-1R 
inhibition on sensory hypersensitivity (18, 21, 22). It is interesting to note that CCL2 
released from primary afferents into the spinal cord also participates in microglia 
recruitment and astrocyte activation in the spinal dorsal horn (29, 72). Therefore, in 
light of the present results, it can be hypothesized that at least part of the previously 
described central effects induced by Sig-1R inhibition during pain conditions may be 
attributable to the actions of this receptor on peripheral sensory neurons, rather than to 
its direct central effects. The development of peripherally-restricted Sig-1R ligands or 
the knockout of Sig-1R in specific subsets of DRG neurons would aid for the study of 
the peripheral actions of these receptors. 
In summary, we found that nerve injury triggered the activation of Sig-1R in 
peripheral sensory neurons, and that this receptor played a key role in the recruitment of 
macrophages/monocytes into the injured DRG, and were thus directly involved in a 
process that is crucial for the development of neuropathic pain. Therefore, Sig-1R 
inhibition may be a potentially effective approach to alleviating neuropathic pain not 
only because of its previously described central effects, but also because of its clear, 
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Figure 1. Comparison of spared nerve injury-induced (SNI) neuropathic mechanical 
allodynia in wild-type and Sig-1R-knockout mice. Von Frey thresholds were recorded 1 
day before (baseline) and 3 and 7 days after SNI in the paws ipsilateral and contralateral 
to the site of surgery. Each bar and vertical line represent the mean ± SEM of the values 
obtained in 8–12 animals. Statistically significant differences between the values 
obtained in the same paw on the day before surgery (baseline) and different days after 
SNI: ** P < 0.01, * P < 0.05; between ipsilateral and contralateral measurements: ## P 
< 0.01; and between wild-type (WT) and sigma-1 knockout (KO) groups stimulated the 
in paw ipsilateral to SNI: †† P < 0.01 (two-way repeated measures ANOVA followed 





Figure 2. Double staining of sigma-1 receptor with the neuronal markers NeuN and 
PGP9.5 in the DRG from naive and spared nerve injury (SNI) wild-type mice. (A) 
Sigma-1 receptor staining (Sig-1R, green) in the DRG persists after SNI in wild-type 
mice, whereas NeuN labeling (red) decreases ipsilateral to SNI. Arrows indicate 
neurons with decreased NeuN staining and clear Sig-1R labeling. (B) Sig-1R labeling 
(green) is present in all PGP 9.5-expressing cells (red) either from non-injured or 
injured DRG samples. Images show representative microphotographs from double 
immunostainings in L4 DRG from naive mice, and ipsilateral and contralateral L4 DRG 





Figure 3. The subcellular distribution of sigma-1 receptor is altered in injured neurons 
in DRG from wild-type mice after spared nerve injury (SNI). (A) and (B) 
Representative microphotographs from double immunostaining for sigma-1 receptor 
(Sig-1R, green), PGP 9.5 (red, A) and ATF3 (red, B) in L4 DRG from naive mice, and 
ipsilateral and contralateral L4 DRG from mice with SNI 7 days after surgery. Arrows 
indicate neurons with Sig-1R staining concentrated at the periphery of the soma. 
Arrowheads indicate neurons with Sig-1R concentrated in close vicinity to the cell 
nucleus. Scale bar 50 μm. (C) Quantification of neurons showing Sig-1R translocation 
in samples from naive animals, and in DRG ipsilateral and contralateral to SNI. N: 
naive, I: ipsilateral; C: contralateral. Statistically significant differences between naive 
and ipsilateral groups: **P < 0.01; and between the values in the ipsilateral and 
contralateral groups: ## P < 0.01 (one-way ANOVA followed by Bonferroni test). (D) 
Quantification of the percentage of neurons with Sig-1R translocation that did or did not 
express ATF3. Statistically significant differences between the values in ATF3+ and 
ATF3− neurons with translocated Sig-1R: **P < 0.01 (Student’s t test). Each bar and 






Figure 4. Spared nerve injury (SNI) induces macrophage/monocyte infiltration in the 
DRG of wild-type mice, which is reduced in sigma-1 receptor knockout mice, whereas 
there is no apparent neutrophil infiltration in DRG from either genotype. 
Macrophage/monocyte (CD45+CD11b+Ly6G− cells) and neutrophils 
(CD45+CD11b+Ly6G+ cells) were determined by FACS in DRG from naive mice, and 
ipsilateral (A) and contralateral (B) DRG from mice with SNI, 1 and 7 days after 
surgery. Each bar and vertical line represent the mean ± SEM of the values obtained in 
4 or 5 batches of DRG. Each batch was obtained with L3 and L4 DRG from 3 animals. 
Statistically significant differences between the values in naive and SNI ipsilateral 
groups: ** P < 0.01; and between DRG ipsilateral to SNI in the WT and KO groups: †† 





Figure 5. Sigma-1 receptor knockout mice show less macrophage/monocyte infiltration 
and reduced levels of IL-6 in comparison to wild-type mice in the DRG after spared 
nerve injury (SNI). (A) Representative microphotographs of double immunostaining for 
IBA-1 (green) and NeuN (red) in L4 DRG from naive mice, and ipsilateral and 
contralateral L4 DRG from mice with SNI 7 days after surgery. Experiments were 
performed in wild-type (WT) mice and sigma-1 knockout mice (KO). Scale bar 50 μm. 
(B) Quantification of the number of macrophages/monocytes (IBA1+ profiles) per 4 × 
104 µm2. Each bar and vertical line represent the mean ± SEM of the values obtained in 
3–6 animals. N: naive, I: ipsilateral, C: contralateral. (C) IL-6 levels in L3 and L4 DRG 
ipsilateral and contralateral to SNI in wild-type (WT) and sigma-1 receptor knockout 
(KO) mice measured by a multiplex immunoassay. Each point and vertical line 
represents the mean ± SEM of the values obtained in 3–5 batches of DRG samples. 
Each batch was obtained with L3 and L4 DRG from 3 animals. (B and C) Statistically 
significant differences between the values in naive and SNI ipsilateral groups: ** P < 
0.01; between ipsilateral and contralateral groups of mice with the same genotype: ## P 
< 0.01; and between DRG ipsilateral to SNI in the WT and KO groups: †† P < 0.01 




Figure 6. DRG neurons with sigma-1 receptor translocation are surrounded by 
macrophages/monocytes forming ring-like structures after spared nerve injury (SNI). 
(A) Representative microphotographs from double immunostaining for sigma-1 
receptor (Sig-1R, green) and IBA-1 (red) in L4 DRG from naive mice, and ipsilateral 
and contralateral L4 DRG from mice with SNI 7 days after surgery. Scale bar 50 μm. 
(B) Quantification of the percentage of neurons with and without Sig-R1 translocation, 
and surrounded by macrophages or not. Each bar and vertical line represent the mean ± 
SEM of the values obtained in 4 animals. Statistically significant differences between 
the values in the groups surrounded and not surrounded by macrophages: ** P < 0.01 




Figure 7. Sigma-1 receptor knockout mice show lower CCL2 levels in DRG after 
spared nerve injury (SNI) than wild-type mice. CCL2 levels in L3 and L4 DRG 
ipsilateral and contralateral to SNI in wild-type (WT) and sigma-1 receptor knockout 
(KO) mice were measured by ELISA. Each point and vertical line represents the mean ± 
SEM of the values obtained in 3–5 batches of DRG samples for each time point. Each 
batch was obtained with L3 and L4 DRG from 3 animals. Statistically significant 
differences between the values from DRG samples from naive and SNI mice: * P < 
0.05, ** P < 0.01; between the values in DRG samples ipsilateral and contralateral to 
SNI within the same genotype: ## P < 0.01; and between the values in DRG ipsilateral 






Figure 8. Proposed actions for the effects of sigma-1 receptor on DRG 
neuroinflammation after nerve injury. In wild-type (WT) mice, injured DRG exhibits 
high levels of CCL2 and a massive infiltration of macrophages/monocytes, which 
clustered mainly around sensory neurons with translocated sigma-1 receptor (Sig-1R), 
accompanied by robust IL-6 increase and mechanical allodynia as a feature of 
neuropathic pain. In contrast, Sig-1R knockout (Sig-1R-KO) mice showed reduced 
levels of CCL2, decreased macrophage/monocyte infiltration into DRG, and less IL6 











































































Suppl. Fig. 1. LPS administration but not spared nerve injury (SNI) induces alterations 
in burrowing behavior. (A) Weight of food pellets burrowed in 30 minutes by wild-type 
(WT) and Sig-1R-knockout mice (KO) mice submitted or not to SNI, is similar 
regardless of the genotype and injury. (B) LPS, administered 3h before testing, reduces 
significantly burrowing behavior in comparison with the saline-injected control group. 
Each bar and vertical line represent the mean ± SEM of the values obtained in 7–11 
animals. Statistically significant differences between the values obtained before the 
treatment with LPS (baseline) and 3 hours after: ** P < 0.01; and between saline or LPS 




Suppl. Fig. 2. DRG samples from sigma-1 receptor knockout mice are devoid of sigma-
1 receptor inmunostaining. Representative microphotographs from double 
immunostaining for NeuN (red) and sigma-1 receptor (Sig-1R, green) in L4 DRG from 
Sig-1R knockout naive mice, and ipsilateral and contralateral L4 DRG from mutant 
















Suppl. Fig. 3. DRG neurons express ATF3 in wild-type mice after spared nerve injury 
(SNI), and show decreased NeuN staining. Representative microphotographs from 
double immunostaining for NeuN (red) and ATF3 (green) in L4 DRG from naive mice, 

















Suppl. Fig. 4. The staining of the neuronal marker PGP 9.5 is stable after spared nerve 
injury (SNI), whereas NeuN expression was reduced or absent in some DRG neurons 
ipsilateral to the injury. Representative microphotographs from double immunostaining 
for PGP 9.5 (red) and NeuN (green) in L4 DRG from naive mice, and ipsilateral and 
contralateral L4 DRG from mice with SNI 7 days after surgery. Arrows indicate 
neurons with decreased NeuN staining and clear PGP 9.5 labeling. Scale bar 100 µm. 
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